Skip to main content
. 2020 May 28;6(1):e001242. doi: 10.1136/rmdopen-2020-001242

Figure 2.

Figure 2

The WOO and slow- versus fast-acting DMARDs. In this figure, the potential effect of slow- versus fast-acting DMARDs on the WOO is drawn for a non-linear scenario. The same hypothesis could be applied in a linear scenario.

DMARDs, disease-modifying anti-rheumatic drugs; WOO, window of opportunity.